The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
I am 27 years old and was born and raised in Even Yehuda, a small town in central Israel, where I learned early on the value of community, responsibility, and giving of myself to others. From a young age, I was motivated academically and socially. I completed high school in three years with high honors, […]
Israeli researchers have developed an innovative method that enables medicine to be manufactured within the body itself. The pioneering approach, not yet tested on humans, uses live, harmless bacteria that act like tiny factories, producing therapeutic proteins inside the body, exactly where they are needed. “We are accustomed to thinking that to introduce a drug into the body, it must be manufactured in a factory and then delivered via a capsule or an injection,” said Prof. Boaz Mizrahi of the Technion – Israel Institute of Technology’s lab for biomaterials in the Faculty of Biotechnology and Food Engineering. “This could be…
In a surprising discovery, researchers at the Technion – Israel Institute of Technology have found that a cellular system tasked with disposing of toxic proteins—crucial in preventing Alzheimer’s disease—may actually be helping the disease spread across the brain. The study, led by Professor Michael Glickman, dean of the Technion’s Faculty of Biology, and postdoctoral researcher Dr. Ajay Wagh, reveals that, instead of breaking down defective proteins inside the cell, neurons may be pushing this “trash” into surrounding brain tissue. Their findings were published recently in the journal Proceedings of the National Academy of Sciences (PNAS). At the heart of the…
In this webinar, discover how the Technion’s leading minds are realizing this vision while also tackling issues of how to overcome age-related motor and cognitive decline. Technion alumnus Prof. Nir Barzilai, M.D., and Prof. Firas Mawase discuss their groundbreaking research on health across the lifespan — and how their work promises to make life’s next […]
A discovery by Prof. Ami Aronheim and his team at the Technion–Israel Institute of Technology shows that the growth of cancerous tumors may actually combat cardiac dysfunction and reduce fibrosis, the scarring process that stiffens the heart muscle. “The failing heart can beat much better in the presence of cancer cells or a tumor,” said lead investigator Aronheim, dean of the Technion’s Ruth and Bruce Rappaport Faculty of Medicine, speaking to The Times of Israel. “This is very surprising,” Aronheim said. Currently, no drugs exist that can reverse fibrosis or improve the heart muscle once it has been damaged, he…
NeuroKaire’s offices on Yigal Alon Street in Tel Aviv are about as far as one can get from the gleaming workspaces of a typical Israeli high-tech company. The parking lot is dark and dirty, the elevator creaks, and there is no doorman, nor a sea view, unlike the surrounding luxury towers. The surprise begins only after stepping through the wide office doors: giant microscopes, highly sophisticated robots, and some of the world’s most advanced medical equipment, all enabling one of the most complex biological feats in existence, turning ordinary blood cells into human brain cells. “We could have been, like…
A technology developed in the laboratory of Prof. Amit Meller from the Technion—Israel Institute of Technology Faculty of Biomedical Engineering marks a significant advancement toward rapid proteome analysis, with far-reaching implications for both fundamental research and disease diagnosis. A 2023 Nature opinion article identified the seven most important emerging technologies to watch—with single-molecule protein sequencing taking the top spot. The article highlighted the pivotal contributions of Prof. Meller’s research group in advancing key technologies toward the commercialization of protein sequencing systems, paving the way for a true revolution in biological and medical research. Since proteins are the body’s fundamental building blocks, their rapid and…
In a 1966 Hollywood film “Fantastic Voyage”, screenplay by Isaac Asimov, scientists are shrunk to a few millimeters and injected into the bloodstream of a dying scientist who has vital information. Their mission: Navigate to his brain and destroy a blood clot before returning to normal size. Fast forward: On sabbatical in Boston in the early 1980s, Rafael rocket engineer Gabriel Iddan encounters Israeli gastroenterologist, Eitan Scapa. “I can’t reach the small intestine with my endoscope,” he says. Jokingly, to Iddan: “Can you shrink a camera and transmitter small enough to swallow and travel through the intestines?” Iddan’s Israeli startup…
Shai Shen-Orr on the Future of Disease Modeling In this newly released podcast, Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion – Israel Institute of Technology, dives into the next frontier of health care: disease modeling. He explains how CytoReason transforms today’s overwhelming biological data into actionable insights that power […]
When he was just 11 years old, Hagai Suissa suffered a traumatic brain injury in a car accident that left him fighting for his life. Twenty-six years later, Dr. Suissa, now 37, has come full circle — returning to the operating room, this time as a neurosurgeon at Ziv Medical Center in Safed. Just a month ago, Suissa completed his residency in neurosurgery at the Galilee Medical Center in Nahariya and began working as a senior physician in Ziv’s newly opened neurosurgery department. For him, the moment marked the culmination of a journey that began in 1999, when he was…
At 15, when a neurological condition took Tobias Weinberg’s ability to speak, aspects of his personality became more difficult to express. Typing to communicate, he struggled to keep up in conversations, especially to make the jokes or sarcastic comments that had been his norm. And his first text-to-voice device was monotone, with Mexican or Spanish accents but not his native Argentinian. “The monotone voices, the timing of interjections and conveying my personality through this new way of communication was definitely frustrating,” wrote Weinberg, now a doctoral student and Siegel PiTech Fellow at Cornell Tech. As part of the Matter of…
Every day, millions of people are discharged after extended hospital stays, but matching these patients with appropriate care facilities can be arduous, often reliant on months-old, inaccurate data. Now, a text message-based, hybrid computer-human system that regularly updates both patients’ and care facilities’ availability statuses, developed by a Cornell doctoral student, is smoothing that time-consuming process. The system was tested at a hospital in Hawaii for 14 months, beginning in early 2022, and helped place nearly 50 patients in care facilities. In fact, the system worked so well, the hospital is still using it. “I worked closely with the people…